Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

NCT06284213 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06284213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06284213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
September 29, 2021
Completion date
July 31, 2027
Enrollment
1,892 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, dementia